---
figid: PMC11387120__ijo-65-04-05684-g02
pmcid: PMC11387120
image_filename: ijo-65-04-05684-g02.jpg
figure_link: /pmc/articles/PMC11387120/figure/F3/
number: Figure 3
figure_title: Drug resistance mechanism of tumor immune microenvironment factors.
caption: Drug resistance mechanism of tumor immune microenvironment factors. Wnt,
  Wingless/Int; Wnt/β-catenin, Wingless/Int classical pathway; NF-κB, The κ-light
  chain of B cells activated by nuclear factor is enhanced; IL-11/IL-11R/gp130/JAK/STAT3,
  Anti-apoptotic signaling pathway; Smad2/3, Mothers against decapentaplegic homolog
  2; STAT3, The gene on chromosome 17; PI3K/AKT/mTOR, classic pathways that respond
  to insulin signals; STAT3/NF-κB, dual signal antitumor; WWOX, REDOX enzyme gene
  containing WW domain; CSF1, macrophage colony stimulating factor; IL, interleukin;
  PD-1, immunosuppressive molecule; CTLA-4, cytotoxic T lymphocyte-associated protein
  4; CCL22, antibody to eosinophil chemotactic protein 22; HIF1α, hypoxia-inducible
  factor; GDF15, growth differentiation factor 15; IGF, insulin-like growth factor;
  PI3K/AKT/survivin, phosphatidylinositol 3-kinase/protein kinase B/survivin signaling
  pathway; CCL8, CC chemokine ligand 8; JAK1, non-receptor tyrosine kinase; VEGF-C,
  vascular endothelial growth factor C; VEGFR3, VEGF receptor 3; MAPK, mitogen-activated
  protein kinase
article_title: 'Drug resistance and tumor immune microenvironment: An overview of
  current understandings (Review)'
citation: Yan Liu, et al. Int J Oncol. 2024 Oct;65(4).
year: '2024'
pub_date: 2024-10-
epub_date: 2024-8-30
doi: 10.3892/ijo.2024.5684
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: D.A. Spandidos
keywords:
- tumor immune microenvironment
- drug resistance
- cancer-associated fibroblasts
- tumor-associated macrophages
- extracellular matrix
---
